Source: Annual Congress 2003 - From gene to breath analysis in airway disorders



Rating:

Share or cite this content

Citations should be made in the following way:
D. Poli, M. Corradi, P. Carbognani, M. Rusca, O. Acampa, A. Mutti (Parma, Italy). Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer. Eur Respir J 2003; 22: Suppl. 45, 1416

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Standardization of exhaled volatile organic compounds (VOCs) measurement Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Diet and alcohol affect exhaled volatile organic compounds (VOCs) Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Exhaled volatile organic compounds in nonrespiratory diseases Source: Eur Respir Monogr 2010; 49: 140-151 Year: 2010 Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation Year: 2012 Volatile organic compounds (VOC) in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds Source: Eur Respir J 2005; 26: Suppl. 49, 373s Year: 2005 Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020